Teva to pay NIS 2.54b in taxes, release 'trapped profits'

Company made announcement Monday night, just hours before an incentives law expired; figure includes back taxes from 2005.

November 11, 2013 19:20
2 minute read.
Finance Minister Yair Lapid at the IDI's Eli Hurvitz conference on economy and society.

FM Lapid at Eilat conference 370. (photo credit: Yossi Zamir)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Pharmaceutical Giant Teva will releasing 'trapped profits' and pay the state of Israel NIS 2.54 billion, including back taxes from 2005, the company announced Monday night, just hours before an incentives law expired.

According to the company, it will pay NIS 2 billion (including a NIS 336m payment it made in may) in the framework of the 2012 "trapped profits law," which expires at midnight Monday. It will pay NIS 840m for tax assessments from 2005-2011, and another expected NIS 833m. for its 4th quarter results.

Be the first to know - Join our Facebook page.

“We have reached a beneficial agreement for Teva and the Israel Tax Authority concerning the release of trapped profits and the closure of pending tax assessments." said Eyal Desheh, Acting President and CEO of Teva. “The agreement generates sources for dividends to our shareholders for years to come and settles tax assessments which had been in dispute for a long time." Desheh stepped into the role temporarily after former CEO Jeremy Levin was pushed out of his position at the end of October.

Monday's announcement follows intense negotiations with the Tax Authority, which hoped to collect NIS 3 billion in trapped profits before the laws expiry. On Sunday, Israel Chemicals came to a similar agreement to pay NIS 380m.

Finance Minister Yair Lapid said he was "happy that Teva also made the right decision in its choice to release some NIS 33 billion in trapped profits." He promised to find a balance between the job creation that tax incentives can spurn as they attract international companies to invest in Israel, and the Treasury's tax revenues.

A May Finance Ministry report elicited a public outcry when it revealed that Teva and Israel Chemicals alongside Intel Israel and Check Point - Israel's four biggest companies, had received 70 percent of all corporate tax benefits in 2010. The NIS 4b. in breaks, given through the Law for the Encouragement of Capital Investment, reduced their average effective tax rates to about 3%.

Though Lapid reacted sharply at the time, last week he seemed to soften his stance on the usefulness of corporate tax breaks to encourage investments.

“We need to oversee the tax benefits for large companies, we need to create better mechanisms for checking them and increasing efficiency; but we must continue to use tax benefits to continue bringing Intel, Cisco, Siemens and Google to Israel, because that’s also what makes us innovative," he said.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection